83 related articles for article (PubMed ID: 17441430)
1. [Expression of PML in carcinogenesis of laryngocarcinoma and nasopharyngeal carcinoma].
Chen W; Yao W; Chen S; Xiao B; Tao Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Feb; 21(3):128-31. PubMed ID: 17441430
[TBL] [Abstract][Full Text] [Related]
2. [The expression and significance of SDF-1/CXCR4 biological axis in laryngeal squamous cell carcinoma and lymph node metastasize].
Zhang L; Xiong C; Wu Y; Shi H; Jing S; Song J; Zhao Z; Shan B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):798-801. PubMed ID: 23259294
[TBL] [Abstract][Full Text] [Related]
3. Loss of promyelocytic leukemia protein in human gastric cancers.
Lee HE; Jee CD; Kim MA; Lee HS; Lee YM; Lee BL; Kim WH
Cancer Lett; 2007 Mar; 247(1):103-9. PubMed ID: 16713073
[TBL] [Abstract][Full Text] [Related]
4. [The expression and clinical pathological significance of PDCD in laryngocarcinoma].
Feng G; Li P; You H; Liu W; Zhang X; Xu X; Sun G; Li F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(1):16-9. PubMed ID: 21469387
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma.
Chan JY; Meng CL; To KF; Leung SF; Chan AT; Lee KK; Johnson PJ
Eur J Cancer; 2002 Aug; 38(12):1600-6. PubMed ID: 12142048
[TBL] [Abstract][Full Text] [Related]
7. [Expression of promyelocytic leukaemia protein in lung carcinomas and clinical significance thereof].
Zhao ZL; Huang QY; Xu S; Zhang L; Zhao HR
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3362-6. PubMed ID: 17313836
[TBL] [Abstract][Full Text] [Related]
8. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
Vincenzi B; Santini D; Perrone G; Russo A; Adamo V; Rizzo S; Castri F; Antinori A; Alloni R; Crucitti PF; Morini S; Rabitti C; Vecchio FM; Magistrelli P; Coppola R; Tonini G
Ann Oncol; 2009 Jan; 20(1):78-83. PubMed ID: 18689862
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of NFAT by promyelocytic leukemia protein.
Lo YH; Wu CC; Shih HM; Lai MZ
Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
[TBL] [Abstract][Full Text] [Related]
11. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
12. CK2 and PML: regulating the regulator.
Lallemand-Breitenbach V; de Thé H
Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
[TBL] [Abstract][Full Text] [Related]
13. [Expression of p15 protein in poorly differentiated nasopharyngeal carcinoma].
Liang C; Zhang F; Zeng X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):591-3. PubMed ID: 15515545
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.
Lo PH; Xie D; Chan KC; Xu FP; Kuzmin I; Lerman MI; Law S; Chua D; Sham J; Lung ML
Cancer Lett; 2007 Nov; 257(2):199-205. PubMed ID: 17720308
[TBL] [Abstract][Full Text] [Related]
15. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
Zhou Y; Xu A; Ling X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
[TBL] [Abstract][Full Text] [Related]
16. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
17. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
[TBL] [Abstract][Full Text] [Related]
18. [Expression of metastasis-suppressor gene nm23H1 product in nasopharyngeal carcinoma].
Huang G; Zeng X; Lu Y; Ning Q; Yang C; Jiang Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):40-4. PubMed ID: 10684060
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of human nuclear distribution C in nasopharyngeal carcinoma].
Chen Y; Yang Y; Lin Z; Peng H; Lu H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):71-3. PubMed ID: 21473139
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
